Proteomic deconvolution reveals distinct immune cells in different body sites in SARS-Cov-2 positive individuals

Severe acute respiratory syndrome <em>coronavirus 2<b> (</b></em>SARS-CoV-2) continues to be a significant public health challenge globally. SARS-CoV-2 is a novel virus, and what constitutes immunological responses in different human body sites in infected individuals is yet to be presented. This study set to determine the various immune cell fractions in gargle solution, bronchoalveolar lavage fluid, nasopharyngeal, and urine samples post-SARS-CoV-2 infection in humans. The data in this repository supports the findings in the above mentioned topic.